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Abstract
Background: Shigella, an enteroinvasive bacteria induces a major inflammatory response responsible for acute rectocolitis
in humans. However, early effect of Shigella flexneri (S. flexneri) infection upon the human mucosa and its
microenvironement, in particular the enteric nervous system, remains currently unknown. Therefore, in this study, we
sought to characterize ex vivo the early events of shigellosis in a model of human colonic explants. In particular, we aimed at
identifying factors produced by S. flexneri and responsible for the lesions of the barrier. We also aimed at determining the
putative lesions of the enteric nervous system induced by S. flexneri.
Methodology/Principal Findings: We first showed that, following 3 h of infection, the invasive but not the non-invasive
strain of S. flexneri induced significant desquamation of the intestinal epithelial barrier and a reduction of epithelial height.
These changes were significantly reduced following infection with SepA deficient S. flexneri strains. Secondly, S. flexneri
induced rapid neuronal morphological alterations suggestive of cell death in enteric submucosal neurones. These
alterations were associated with a significant increase in the proportion of vasoactive intestinal peptide (VIP)
immunoreactive (IR) neurons but not in total VIP levels. The NMDA receptor antagonist MK-801 blocked neuronal
morphological changes induced by S. flexneri, but not the increase in the proportion of VIP-IR.
Conclusions/Significance: This human explant model can be used to gain better insight into the early pathogenic events
following S. flexneri infection and the mechanisms involved.
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Introduction
Diarrheal diseases induced by bacterial, viral or parasitic
pathogens represent a major world-wide public health problem.
Although mortality from diarrheal diseases has been reduced by
about 50% over the past 20 years, they still account for 2.5
millions deaths/year [1]. Species of the genus Shigella flexneri (S.
flexneri) are among the most frequently isolated pathogens from
patients with diarrhoea [2]. S. flexneri, one of the 4 species of Shigella
is the hyperendemic species in the most impoverished areas,
responsible for 10% of all diarrhoeal episodes in children younger
than 5 years [3].
The pathogenesis of shigellosis is a multi-step process that has
been extensively studied over the past years mainly in animal
models or in vitro. Schematically, after ingestion, S. flexneri colonizes
the colon, translocates through the intestinal barrier via M cells,
and causes severe destruction of the intestinal epithelium in
response to a major intestinal inflammatory response [4,5]. S.
flexneri triggers an acute inflammation in part due 1) to apoptosis of
monocytes and macrophages, which widely release pro-inflamma-
tory cytokines and 2) to the stimulation of the innate immune
response via the activation of Nod- and Toll-like receptors by
bacterial cell components [6]. This inflammation facilitates the
intestinal barrier rupture and bacterial spread within intestinal
epithelial cells at a distance from the initial entry site, further
amplifying the inflammatory response and mucosal damage [6].
Although the mechanisms and pathways of infection of S. flexneri
have been largely identified in animal models [7–9], few precise
data are available in humans, who are the only naturals host for
the bacteria, especially at early times of infection.
Entry of S. flexneri in host cells is mediated by the type III
secretory system (TTSS) which allows direct activation of
components of the cytoskeleton by delivery of dedicated bacterial
factors [4]. Other proteins secreted by S. flexneri could also be
involved in these early events. Among them, the serine protease
SepA participates in the pathogenic events induced by S. flexneri
[10]. Indeed, infection of rabbit ileal loops by S. flexneri SepA
mutant reduced mucosal atrophy and tissue inflammation induced
by the wild type [11]. However, the role of SepA in the effects of S.
flexneri in the human colon remains currently unknown.
Alterations of the enteric nervous system (ENS) may be involved
in the course of S. flexneri infection, thus participating in both acute
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symptoms. In particular, shigellosis increases the risk to develop
post-infectious like symptoms such as irritable bowel syndrome
[12,13]. The ENS, an integrated neuronal network present all
along the gut, controls major gastrointestinal functions [14]. In
particular, submucosal neurones and glial cells, which densely
innervate the mucosa, are key components controlling intestinal
barrier functions such as paracellular permeability or intestinal
epithelial cell proliferation [15]. In pathological conditions, such as
intestinal inflammation, gastrointestinal dysfunctions are associat-
ed with changes in the neurochemical phenotype or degenerative
process in the ENS [16]. However, the effects of S. flexneri upon the
phenotype and survival of enteric neurons remain totally
unknown, especially in human tissues.
Therefore, the goals of this study were first to characterize ex vivo
the early events of shigellosis in a model of human colonic tissue.
Second, we aimed to identify factors produced by S. flexneri and
responsible for the lesions of the barrier. In particular, we focussed
onto the role of SepA, a factor non dependent of the type III
secretion apparatus. Finally, we aimed to characterize the putative
lesions of the ENS induced by S. flexneri in this human model.
Materials and Methods
Shigella flexneri (S. flexneri)
Four strains of S. flexneri were used in this study: 1) the wild type
S. flexneri 5a (M90T) that harbors a virulence plasmid encoding its
invasive phenotype, thereafter called ‘‘M90T’’, 2) the plasmid-
cured mutant which is non-invasive, thereafter referred as
‘‘BS176’’, 3) M90T deleted for sepA, a plasmid gene encoding
for a major serine protease secreted by S. flexneri, thereafter called
‘‘SepA2‘‘ and 4) BS176 expressing SepA, thereafter referred as
‘‘SepA+’’. These four strains were stored at +4uC on Petri dishes
containing 30 ml of Tryptic Soy Agar (Difco, Becton Dickinson)
and Congo red at a concentration of 0.01% (Merck, Darmstadt).
Eighteen hours before the experiment, one colony was resus-
pended in 10 ml of tryptic soy broth and cultured overnight at
37uC. Before tissue infection, bacteria were adjusted to 10
9cfu/ml
by OD measurement (600 nm) and diluted in fresh broth for 2 h
in order to harvest bacteria in the exponential growth phase.
Ex vivo human colonic preparations
Organotypic culture model. Tissue specimens were
obtained from 30 patients (mean age 61 years (21–91))
undergoing surgical resection for colonic adenocarcinoma. None
of the patients had bowel obstruction or other colon disease.
Specimens were taken at a distance from the tumor in
macroscopically and histologically normal areas and immediately
processed in the Pathology Department. According to the
guidelines of the French Ethics Committee for Research on
Human Tissues, these specimens were considered ‘‘residual
tissues’’, not relevant to pathological diagnosis. All specimens
were collected prior August 2007. At that time, the specimens
considered as ‘‘residual tissue’’ were not subjected to patient
consent.
Tissues were placed in oxygenated sterile Krebs solution
containing (in mM: 117 NaCl, 4.7 KCl, 1.2 MgCl2 6H2O, 1.2
NaH2PO4, 25 NaHCO3, 2.5 CaCl2 2H2O and 11 glucose) and
then rapidly transported to the laboratory for experiments. The
specimen was pinned flat with the mucosa down in a dissection
dish containing ice-cold sterile oxygenated Krebs solution which
was changed every 10–15 min. Tissue preparations taken from
intertaenial regions were 4–7 cm long in circumferential direction,
and 4–5 cm long in longitudinal direction.
The serosa and circular muscle were removed under a
dissection microscope. The mucosa and submucosa fragments
were directly cultured in a Petri dish in the presence of the
different strains of S. flexneri. The culture medium (Dulbecco’s
modified Eagle’s medium/F12; Sigma; St Quentin Fallavier,
France) was supplemented with 10% heat-inactivated fetal calf
serum, glutamine (all from Sigma) and 2.1 g.l
21 NaHCO3. Four
different strains of S. flexneri (M90T, BS176, SepA2 and SepA+)o r
no bacteria (control tissues) were added to the culture medium.
The fragments were maintained for 3 h at 37uC in a humidified
incubator containing 5% CO2 and air, on a rocking tray. At the
end of the experiments, supernatants were removed and
immediately stored at 280uC.
Transmission electron microscopy
For transmission electron microscopy, small sized samples
(about 7 mm border length) of the mucosal-submucosal tissue
layer were immediately fixed by immersion in 0.1 M cacodylate
buffer containing 2.5% glutaraldehyde and 2% paraformaldehyde
at pH 7.4 for 24 h. Specimens were post-fixed in 1% OsO4 and
stained ‘en bloc’ with 2% uranylacetate. After dehydration in
graded alcohol concentrations, the specimens were embedded in
araldite. Semi-thin sections were stained with methylene blue and
azure II to visualize the regions of interest, in particular the
enterocytes lining and the lamina propria mucosae. Ultrathin
sections were cut and stained with lead citrate and examined with
a transmission electron microscope (Philips, EM109). The images
were recorded both by conventional films (Agfa) and digital image
system (Soft Imaging Systems, Mu ¨nster, Germany).
Immunohistochemistry
Fragments were fixed for 4–6 h in 0.1 M phosphate-buffered
saline (PBS) containing 4% paraformaldehyde at room tempera-
ture. Following fixation, tissues were washed in PBS and pinned in a
dissection dish. The mucosa was then removed under a dissection
microscope and the submucosal plexus of Meissner (located directly
under the mucosa) was carefully dissected with fine scissors.
Immunohistochemical staining and analysis of the
human colonic mucosa
The mucosa was dehydrated and embedded in paraffin.
Sequential sections of mucosa (5 mm in thickness) were made.
Infected tissues were observed by classical microscopy following
hematoxylin-eosin staining. The length of the epithelial desqua-
mation and the height of the surface epithelium were measured in
10 fields examined under an Olympus IX 50 fluorescence
microscope. Pictures were acquired with a black and white video
camera (Mod. 4910, Cohu Inc., SL Microtest, Jena, Germany)
connected to a Macintosh computer through a frame-grabber card
(Scion Image, SL Microtest).
Immunohistochemical staining of the human
submucosal plexus
The submucosal plexus was then permeabilised for 1 h in PBS/
NaN3 containing 0.5% Triton X-100 (Sigma) and 4% horse serum
(Sigma), before being incubated with the primary antibodies i.e.,
mouse anti-VIP (1:1000; Biogenesis, UK) diluted in PBS/NaN3,
4% horse serum, and 0.5% Triton-X overnight at room
temperature. Following incubation with primary antisera, the
tissue was washed three times with PBS and incubated for 3 h with
secondary antibodies coupled to donkey anti-mouse IgG conju-
gated to 7-amino-4-methyl-coumarin-3-acetate (AMCA) (1:50;
Euromedex, Mundolsheim, France). In the next step, the tissue
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(1:2000; Biovalley; Marne La Valle ´e, France) overnight at room
temperature. Following incubation with the primary antisera, the
tissue was washed with PBS and incubated for 3 h with donkey
anti-rabbit IgG conjugated to fluorescein isothiocyanate (FITC)
(1:200 Immunotech, Marseille, France). Specimens were viewed
under an Olympus IX 50 fluorescence microscope fitted with
adequate filter cubes. Pictures were acquired with a black and
white video camera (Mod. 4910, Cohu Inc., SL Microtest, Jena,
Germany) connected to a Macintosh computer through a frame-
grabber card (Scion Image, SL Microtest).
Identification of neuronal cell populations
The immunohistochemical study was performed by analysing
an average of 25 submucosal ganglia in each preparation. The
proportions of neurochemically-identified populations are ex-
pressed relatively to the number of NSE-positive neurones per
ganglion, which was set to represent 100% of neurones. For the
quantitative analysis of NSE immunoreactivity, fluorescence
intensity of at least 20–30 submucosal neurons was analysed in
each preparation following a method similar to the one previously
described [17]. In brief, the outline of the neuron was defined with
the cursor and mean fluorescence level of the pixels within the
delimited area was determined using Scion Image software
program. The background fluorescence of the area next to each
ganglia was subtracted from the fluorescence level of each neuron.
Interleukin-8 and VIP measurements
Supernatants of tissue cultures were collected and IL-8 protein
levels were determined by ELISA (B&D, France) according to the
manufacturer’s instructions. Each sample was assessed in dupli-
cate. For determination of VIP concentration in the submucosal
plexus, the proteins of the submucosa were extracted using RIPA
lysis buffer (Millipore, Saint Quentin en Yvelines, France)
containing protease inhibitor cocktail (Roche Diagnostics, Meylan,
France) and levels of VIP were measured by ELISA (Bachem, Weil
am Rhein, Germany).
Pharmacological study
MK-801(Sigma) (50 mM) was applied at least 30 minutes prior
to addition of S. flexneri.
Statistical methods
Each single experiment comparing at least two conditions was
performed on tissues obtained from the same subject. Each set of
experiments was repeated at least five times. Data are expressed as
mean6SEM when normally distributed, or as the median (25%–
75% percentiles) when non-normally distributed. A paired or
unpaired t-test, a Mann-Whitney test, an one-way analysis of
variance (ANOVA) followed by a Bonferroni t-test, were
performed to compare different populations. Differences were
considered as significant for p,0.05.
Figure 1. Transmission electronic microscopy of human colonic mucosa infected or not with S. flexneri (M90T). (A) Control tissue shows
normal epithelial lining with regular basolateral folds and absence of bacteria in the lamina propria. (B) Tissue infected with M90T shows regions of
partially detached and vacuolated epithelial cells or regions with complete detachement of epithelial lining. (C) Tissue infected with M90T showing
regions of detached epithelial cells and presence of bacteria within the lamina propria adjacent to granulocytes (white square) (D). Magnified view of
the selected area from C showing bacteria (arrow) close to granulocytes. (E) Granulocyte containing an intracellular vacuole filled with bacteria (white
square). (F) Magnified view of the selected area from E showing two intracellular bacteria (arrows). Bar: 10 mm (A, B, C), 2 mm (D), 1 mm (E), 0.5 mm (F).
doi:10.1371/journal.pone.0004713.g001
Human Mucosa and Shigella
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1. Early effects of S. flexneri on human colonic
epithelium
1.1 Epithelial alterations induced by S. flexneri. We
first examined the early alterations induced by S. flexneri on the
human colonic epithelium using transmission electronic
microscopy (n=5). Control tissues showed normal epithelial
lining with normal basolateral folds and without bacteria in the
lamina propria (Figure 1A). In contrast, tissues incubated for
3 hours in the presence of the invasive strain of S. flexneri (M90T)
showed areas of detached and vacuolated epithelial cells and also
regions of complete detachement of the epithelial lining
(Figure 1B,C). No bacteria was observed inside epithelial cells
but in contrast, bacteria could be clearly visible beyond the
epithelial lining, in the lamina propria, close to granulocytes
(Figure 1C,D), or even in intracellular vacuoles of granulocytes
(Figure 1E,F). No significant alteration of the intestinal epithelial
barrier was observed following incubation with the non invasive
strain of S. flexneri, BS176 (data not shown). Detection of S. flexneri
infection foci using anti-S. flexneri 5a antibody showed the presence
of sub-epithelial foci in tissues cultured with M90T but no
intraepithelial bacteria (data not shown). No sub-epithelial foci of
bacteria was visualized in tissues cultured with BS176 or in control
tissues (data not shown).
In order to further quantify these alterations, desquamation and
height of epithelial lining were analyzed using haematoxylin-eosin
staining (Figure 2A–C). After 3 h of incubation, M90T induced a
significant increase in surface epithelium desquamation as com-
pared to BS176 and control tissues (respectively 46632, 9612,
060%; p=0.007 and p,0.001; n=10) (Figure 2D). Moreover,
M90T significantly reduced the epithelial height as compared to
BS176 and control tissues (965, 1464a n d1 6 64 mm; respectively,
p=0.001 and p=0.012; n=10) (Figure 2E).
At the end of the 3 h culture, surprisingly, IL-8 levels in the
culture medium of control tissue was significantly larger than
following incubation with M90T but not with BS176 (Figure 3).
1.2 SepA is involved in morphological alterations
induced by S flexneri. As compared with M90T, M90T
SepA2 infected tissues showed a significant decrease in surface
epithelium desquamation (867v s4 6 632%; p=0.03; n=10) and
a significantly higher epithelial height (1363v s9 65 mm; p=0.02;
n=5) (Figure 4A,B). There was no difference between BS176
SepA+ and BS176 in terms of epithelial desquamation or epithelial
height (Figure 4A,B), suggesting that SepA is necessary but not
sufficient to induce these alterations.
2 Early effects of S. flexneri upon enteric neurons
2.1 Morphological alterations suggestive of neuronal
damages. In order to determine whether M90T is able to
Figure 2. Effects of S. flexneri infection on the epithelium morphology of the human colon assessed by optical microscopy. (A)
Infection of the colonic specimen for 3 h with the invasive strain of S. flexneri (M90T) induced significant desquamation of the surface epithelium. (B)
In tissue infected for 3 h with the non-invasive strain (BS176), only slight desquamation could be observed. (C) No surface epithelium desquamation
was observed in control non-infected tissues cultured for 3 h. (D) Quantitative analysis of colonic morphological alterations revealed that M90T
induced a significant desquamation of the surface epithelium as compared to tissues infected with BS176 and non-infected tissues. (E) In addition,
M90T induced a significant reduction in the height of the surface epithelium as compared to BS176 and non infected tissues. Data are expressed as
mean6SEM (n=10, * p,0.05).
doi:10.1371/journal.pone.0004713.g002
Human Mucosa and Shigella
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performed quantitative and qualitative histological and
immunohistochemical studies. TEM showed that M90T induced
degenerative changes in submucosal neurons and nerve fibers such
as cell shrinkage, axonal swelling, multilamellar cytoplasmic bodies
and chromatin alterations of nuclei, as compared to control tissues
(Figure 5A–D). Degenerative changes such as pycnotic cell nucleus
were also observed in enteric glial cells (Figure 5E–F).
Immunohistochemical studies showed that M90T also induced a
significant decrease in the intensity of NSE labelling of enteric
neurons (245611%; n=8; p,0.001) as compared to BS176
(Figure 6 A–C). M90T altered also neuronal morphology,
decreasing the size and in particular the cytoplasm of neurons
but not of the nuclei as compared with BS176 (Figure 6D).
However, the total number of neurons per ganglia identified with
NSE was similar in tissues infected with M90T and BS176 (662v s
761; n=8; p=0.31). Interestingly, the significant decrease in
NSE labeling of enteric neurons and altered neuronal morphology
induced by M90T was blocked by MK-801 (Figure 6C).
2.2 Alteration of expression of enteric neuro-
mediators. In preparations incubated with BS176,
immunohistochemical analysis of submucosal neurons showed
that29.566.8% of NSE-immunoreactive (IR) neurons were VIP-
IR. Following incubation with BS176, the proportion of VIP-IR
submucosal neurons was similar to that observed in control (non-
infected) tissues (34.566.1%). In contrast, a significant increase
in the proportion of VIP-IR neurons (49.764.1% of NSE-IR;
p,0.001; n=11) was observed following incubation with M90T
in comparison to incubation with BS176 (Figure 7 A–D). In
contrast, measurement of VIP level by ELISA in the submucosa
containing the submucosal plexus revealed that VIP levels were
similar in control condition compared to the condition following
incubation with M90T or BS176 (Figure 7E). Addition of MK-
801 did not prevent the increase in the proportion of VIP-IR
neurons induced by M90T, as compared to control (data not
shown).
Discussion
In this mainly descriptive study, we sought to analyze the early
histological effects of S. flexneri infection upon human colonic
tissues, with a specific focus upon the intestinal epithelial barrier
(IEB) and the ENS. Using an ex vivo human organ culture model,
we showed that the invasive but not the non invasive strain of S.
flexneri induced significant desquamation of the IEB which was
significantly reduced following infection with SepA deficient S.
flexneri strains. In addition, S. flexneri also induced rapid neuronal
morphological alterations suggestive of cell death. These alter-
ations were associated with a significant increase in the proportion
of VIP-IR neurons. Morphological changes induced by S. flexneri
but not the increase in VIP-IR were blocked by the NMDA
receptor antagonist MK-801.
Figure 4. Role of SepA upon epithelial morphology in the human colon induced by S.flexneri. Tissues were infected for 3 h with various
strains of S.flexneri : invasive strain (M90T), non-invasive strain (BS176), invasive strain deleted for SepA (M90T SepA2), non-invasive strain expressing
SepA (BS176 SepA+). (A) M90T SepA2 induced a significant reduction in the epithelial desquamation as compared to M90T. However, BS176 SepA+
did not increase epithelial desquamation as compared to BS176. (B) M90T SepA2 induced a significant increase in the height of the surface
epithelium as compared to M90T and BS176 SepA+ reduced the epithelial height as compared to BS176. Data are expressed as mean6SEM (n=10, *
p,0.05 as compared to M90T).
doi:10.1371/journal.pone.0004713.g004
Figure 3. IL-8 secretion by colonic explants following infection
with strains of S.flexneri. Following 3 h culture, IL-8 levels were
significantly reduced following infection with the invasive strain (M90T)
as compared to control non-infected tissue. In addition, no significant
difference in IL-8 secretion following infection with the non-invasive
strain (BS176) was observed as compared to control or following M90T
infection. Data are expressed as mean6SEM (n=4, * p,0.05).
doi:10.1371/journal.pone.0004713.g003
Human Mucosa and Shigella
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understanding the pathophysiology of shigellosis, including guinea
pigs, rabbits, mice or macaques. However, higher primates and
humans are the only natural hosts for S. flexneri. Interspecies
differences in terms of immune response or ENS phenotype can
therefore limit the extrapolation of animal studies to humans. In
addition, the absence of data describing early effects of shigellosis
in humans is mainly due to the lack or scarse material from
Figure 5. Transmission electronic microscopy of submucosal ganglia from human colonic explants infected or not with the invasive
strain of S. flexneri (M90T). (A) Submucosal ganglia from non-infected control tissues showed neurons with normal size and shape (double arrows
indicating maximal cellular diameter). (B) In contrast, submucosal ganglia from tissues infected with M90T for 3 h showed neuronal cell shrinkage. (C)
Submucosal ganglia containing neurons with various stages of cell shrinkage: intact neuron (empty arrow), neuron with beginning cell shrinkage (filled arrow),
neuron with advanced cell shrinkage (white square). (D) Magnified view of the selected area in C showing the presence of multilamellar bodies (empty arrow),
the presence of lipofuscin granula (filled arrow) and also swollen neuronal processes (arrowhead). (E) Nerve fiber bundle observed in tissue infected with M90T
showing axonal swelling (arrowhead) and also the presence of pycnotic enteric glial cell nucleus (arrow). (F) Magnified view of the selected area in E showing
condensedheterochromatineofcellnucleusandthepresenceoflysosomaticvesicle(arrowhead)inanentericglialcell.Bar:10 mm(A,B,C),2mm(D,E),1mm(F).
doi:10.1371/journal.pone.0004713.g005
Human Mucosa and Shigella
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disease and symptoms. In this context, our model has the
advantage to allow the characterization of early events following
S. flexneri infection in the human colon upon both the IEB and the
ENS. It also presents the advantage over reductionist cellular
models to integrate various components of the mucosa such as
IEC, submucosal neurons and resident inflammatory cells.
One major finding of the study was the presence of a massive
desquamation of surface epithelium induced by S. flexneri, as early
as three hours post-infection. These results are reminiscent of
observations obtained in vivo, both in animal models and in
patients with shigellosis [7,8]. In particular, human intestinal
segments grafted into SCID mice infected with S. flexneri showed
focal desquamation of the epithelial lining without ulcerations,
similar to our observations [8]. Interestingly, the lesions of the
mucosa were not reduced in polynuclear deficient mice [8]. This is
consistent with our observations since no recruitment of
neutrophils can occur in the colonic explants used in our
experiments. In addition, damages of the mucosa occurred in
area devoid of M cells suggesting that, in our model, S. flexneri does
not require entry through Peyer’s patches. A striking finding was
the rapidity of the lesions induced by S. flexneri which occurred
within 3 h post-infection. This could be due to the high inoculum
of bacteria used and the absence of peristaltism and secretory
response in our ex vivo model. In addition, a basal inflammation in
the explant, probably due to hypoxic conditions generated by the
culture and absence of vascularisation, might also have potentiated
the mucosal alterations induced by S. flexneri [9]. Interestingly, no
bacteria was identified within intestinal epithelial cells, although
they were present in some immune cells, but mainly directly
beneath the shedding epithelial layer. This observation is also
consistent with in vivo animal studies showing few bacteria in the
epithelium but localized mainly in the lamina propria and
submucosa [7–9].
Figure 6. Effects of S. flexneri upon morphology of submucosal neurons. (A) Submucosal neurons identified with NSE showed altered
morphology following 3 h infection with the invasive strain of S. flexneri (M90T) as compared to the non-invasive strain (BS176) (B). (C) In addition,
quantitative analysis revealed that M90T induced a decrease in intensity of NSE labelling as compared to BS176 (n=8, p,0.001). Interestingly, this
decrease in intensity was prevented following pre-incubation of the NMDA receptor antagonist, MK-801 (50 mM). (D) Furthermore, M90T decreased
the size of the cytoplasm but not of the nucleus in submucosal neurons as compared to BS176 (n=6, *p=0.002). Bar: 25 mm.
doi:10.1371/journal.pone.0004713.g006
Human Mucosa and Shigella
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that SepA plays a key role in the generation of mucosal damages
induced by S. flexneri. Indeed, invasive bacteria deficient for SepA
significantly reduced epithelial damage. Our results extend to
human tissue the role of SepA described in rabbit, where SepA
deficient S. flexneri significantly reduced the ability of S. flexneri to
induce mucosal atrophy and tissue inflammation [11]. The
mechanisms of action of SepA, a serine protease, remain unknown
although studies have suggested that proteases via their activation
of protease activated receptor are involved in the pathogenesis of
GI inflammation, in part by increasing paracellular permeability
[18–20]. Interestingly, an increase in paracellular permeability is
observed in human mouse xenograft model prior to any mucosal
damage [8] but the involvement of SepA in these effects remain
unknown.
One surprising and unexpected finding of this study was the
decrease in IL-8 induced by S. flexneri in our model. This result can
probably be explained in part by recent findings showing that S.
flexneri produces various anti-inflammatory proteins, which
dampen the inflammatory response induced by the bacteria.
Indeed, proteins encoded and secreted by S. flexneri such as OspG
or OspF prevent nuclear translocation of NF-kB or impair the
accessibility of NF-kB to promoters including IL-8, respectively
[21]. The action of these proteins could be unraveled in our model
as non-infected colonic tissue secretes high level of IL-8, probably
due to the hypoxia of the explants, as previously reported [22].
The decrease of IL-8 secretion induced by S. flexneri could also be
due to the death of IL-8 secreting cells such as IEC, immune cells
or even neurons [17].
Finally we showed that S. flexneri has the potential to induce
degenerative processes both in enteric neurons and glial cells.
Until recently, only mucosal components of the gut such as
epithelial cells, immune cells were sought to be the target of S.
flexneri. Invasion of neurons by S. flexneri is probably not necessary
to induce neuronal damages as 1) no bacteria were detected both
by means of transmission electronic microscopy and immunohis-
tochemical methods, 2) the effects are significantly reduced with an
NMDA receptor antagonist. This latter suggest that excitotoxic
effects of glutamate could be involved in neurodegenerative
processes induced following infection with S. flexneri. A previous
study has shown that glutamate, via the activation of NMDA
receptors, can induce cell death in enteric neurons in vivo or ex vivo
[23]. The origin of the glutamate responsible for these effects is
currently unknown but could be produced by S. flexneri itself, cells
of the mucosal environment or even neurons. The increase in the
proportion of VIP-IR neurons observed in this study is probably
more to be associated with neurodegenerative processes than to
changes in neuronal phenotype. Indeed, the total VIP level in the
submucosal plexus was not altered following incubation with S.
flexneri, as compared to controls. Therefore, the increase in the
proportion of VIP-IR enteric neurons is probably due to reduced
axonal transport of VIP and its subsequent accumulation in the
neuronal cell body. Indeed, axonal transport is significantly
affected and reduced during early neurodegenerative processes
[24].
In conclusion, using an ex vivo model, we have shown that
infection by S. flexneri induces rapid mucosal and neuronal
alterations in the human colon. In particular, we have shown
the major role of SepA in the induction of mucosal desquamation
while NMDA dependent pathways could account for S. flexneri –
induced degenerative processes in the ENS. Finally, this human
model should allow us to gain better insight into the early
pathogenic events following S. flexneri infection and the mecha-
nisms involved.
Figure 7. Effects of S. flexneri on the expression of vasoactive intestinal peptide (VIP) in submucosal neurones. In tissues infected with
the non-invasive strain of S. flexneri (BS176), some NSE-immunoreactive (IR) neurons (A) were faintly VIP-IR (B). In contrast, following M90T infection,
NSE-IR neurons (C) were strongly VIP-IR (D). Analysis of VIP content in submucosal preparation containing submucosal plexus revealed no difference
in VIP content between tissue infected with M90T, BS176 or non-infected control tissue (n=11). Bar: 25 mm.
doi:10.1371/journal.pone.0004713.g007
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